0001140361-21-011708.txt : 20210405 0001140361-21-011708.hdr.sgml : 20210405 20210405214937 ACCESSION NUMBER: 0001140361-21-011708 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210325 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guido Ronald CENTRAL INDEX KEY: 0001853664 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 21807984 MAIL ADDRESS: STREET 1: C/O BROOKLYN IMMUNOTHERAPEUTICS LLC STREET 2: 140 58TH STREET, BUILDING A, SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ALROY INDUSTRIES INC DATE OF NAME CHANGE: 19850411 3 1 form3.xml FORM 3 X0206 3 2021-03-25 0 0000748592 Brooklyn ImmunoTherapeutics, Inc. BTX 0001853664 Guido Ronald 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220 true See Remarks Common Stock 102112 D Interim Chief Executive Officer and Chief Development Officer. Exhibit List: Exhibit 24 - Power of Attorney /s/ Mark L. Johnson, Attorney-in-Fact for Ronald Guido 2021-04-05 EX-24 2 ex24.htm EXHIBIT 24
Exhibit 24

POWER OF ATTORNEY
 (For Executing Forms ID, 3, 4 and 5 for Filing with the Securities and Exchange Commission)
 
Know all by these present, that the undersigned hereby constitutes and appoints each of Rema Awad and Mark L. Johnson of K&L Gates LLP, severally with full power of substitution, as the undersigned’s true and lawful attorneys‑in‑fact to:
 
(1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, Uniform Application for Access Codes to File on EDGAR, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or any rule or regulation thereunder;
 
(2)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the SEC from time to time Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Exchange Act and the rules thereunder in the undersigned’s capacity as an officer, director or beneficial owner of more than ten percent of a registered class of securities of various entities (collectively, the “Company”);
 
(3)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such forms with the SEC and any stock exchange, self-regulatory association or any similar authority; and
 
(4)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by either attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in the attorney-in-fact’s discretion.
 
The undersigned hereby grants to each such attorney‑in‑fact, severally, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that either such attorney‑in‑fact, or such attorney‑in‑fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that, in serving in such capacity at the request of the undersigned, neither of the foregoing attorneys-in-fact, or their substitutes, is assuming (nor is the Company assuming) any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.
 
This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the time as of which the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation of this Power of Attorney by the undersigned in a signed writing delivered to the Company and the foregoing attorneys‑in‑fact and (c) with respect to either attorney-in-fact, the time as of which such attorney-in-fact is no longer affiliated with K&L Gates LLP.
 
In Witness Whereof, the undersigned has caused this Power of Attorney to be executed as of the date written below.
 
Date:   March 24, 2021

By:
/s/ Ronald Guido
 
 
Name: Ronald Guido